Capula Management LTD Abb Vie Inc. Call Options Transaction History

Capula Management LTD

$9.23 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $425,984 - $518,258	-2,600 Reduced 50.98%	2,500 $493,000
Q2 2024 Aug 05, 2024	BUY	$154.79 - $180.76 $789,429 - $921,876	5,100 New	5,100 $874,000
Q3 2023 Nov 03, 2023	SELL	$133.59 - $154.65 $18.2 Million - $21.1 Million	-136,500 Reduced 95.66%	6,200 $924,000
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $8.26 Million - $10.3 Million	-62,300 Reduced 30.39%	142,700 $19.2 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $7.03 Million - $8.09 Million	48,600 Added 31.07%	205,000 $32.7 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $4.9 Million - $5.87 Million	35,400 Added 29.26%	156,400 $25.3 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $101 Million - $116 Million	-753,500 Reduced 86.16%	121,000 $16.2 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $113 Million - $144 Million	822,500 Added 1581.73%	874,500 $134 Million
Q1 2022 May 17, 2022	BUY	$131.98 - $163.75 $6.86 Million - $8.52 Million	52,000 New	52,000 $8.43 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $6.03 Million - $7.63 Million	-56,100 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $3.84 Million - $4.36 Million	36,100 Added 180.5%	56,100 $5.98 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $5.3 Million - $5.91 Million	-50,400 Reduced 71.59%	20,000 $2.23 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $4.51 Million - $4.97 Million	44,100 Added 167.68%	70,400 $7.62 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $2.12 Million - $2.86 Million	26,300 New	26,300 $2.82 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $13.3 Million - $15.6 Million	-155,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $5.87 Million - $7.85 Million	80,000 Added 106.67%	155,000 $15.2 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $3.23 Million - $4.89 Million	50,000 Added 200.0%	75,000 $5.71 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $8.14 Million - $10.2 Million	-112,900 Reduced 81.87%	25,000 $2.21 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $8.68 Million - $10.4 Million	137,900 New	137,900 $10.4 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capula Management LTD with notifications on news.

Account